赛默飞世尔科技
TMO
690.00
-6.49
-0.93%
赛默飞世尔科技
US · TMO
#80 按市值排名
上市于 1970
690.00
-6.49
-0.93%
实时 - 追踪5344个代码 - 心跳于282秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了25家。
- 机构持股总比例下降了0.2个百分点。
机构持股
- 机构持股比例
- 92.83% -0.16pp
- 机构数量
- 3,108 -25
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund75.50%
Public Company5.62%
Hedge Fund3.91%
Government Pension Fund2.05%
Private Company2.00%
Sovereign Wealth Fund1.46%
VC/PE Fund1.00%
Family Office/Trust0.55%
Corporate Pension Plan0.31%
Other7.62%
主要股东 截至 2026-06-30
BlackRock
8.36% · 30.92M 股
Vanguard Capital Management, LLC
7.13% · 26.36M 股
State Street Global Advisors
4.55% · 16.83M 股
Capital Research
3.71% · 13.73M 股
FMR
3.32% · 12.26M 股
Other
72.93%
Geode Capital Management, LLC
2.27% · 8.38M 股
Morgan Stanley
1.78% · 6.57M 股
Vanguard Portfolio Management, LLC
1.68% · 6.23M 股
T. Rowe Price Group, Inc.
1.39% · 5.13M 股
Norges Bank Investment Management
1.38% · 5.09M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 22次买入 · 28次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Marc Casper | Chairperson & CEO | 0.03% |
| Michel Lagarde | Chief Operating Officer | 0.02% |
| Scott Sperling | Lead Independent Director | 0.02% |
| Stephen Williamson | Senior Vice President | 0.01% |
| Gianluca Pettiti | Executive Vice President | 0.01% |
| Michael Shafer | Senior VP & President of Pharma Services Group | 0.00% |
| Nelson Chai | Independent Director | 0.00% |
| Frederick Lowery | Senior VP & President of Customer Channels | 0.00% |
| Lisa Britt | Chief Human Resources Officer & Senior VP | 0.00% |
| Michael Boxer | General Counsel | 0.00% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-25 | Scott Sperling | Lead Independent Director | Other Derivative Acquisition | +62 | -- |
| 2026-09-25 | Jennifer Johnson | Director | Other Derivative Acquisition | +46 | -- |
| 2026-09-25 | Karen Lynch | Director | Other Derivative Acquisition | +46 | -- |
| 2026-09-25 | Dion Weisler | Independent Director | Other Derivative Acquisition | +55 | -- |
| 2026-09-25 | R. Keith | Independent Director | Other Derivative Acquisition | +46 | -- |
| 2026-08-30 | Gianluca Pettiti | Executive Vice President | Automatic Disposition | -400 | $614.38 |
| 2026-08-30 | Gianluca Pettiti | Executive Vice President | Derivative Exercise and Sale | -3,733 | $309.63–614.38 |
| 2026-08-27 | Marc Casper | Chairperson & CEO | Sale to Issuer | -1,256 | $622.18 |
| 2026-08-27 | Thomas Shropshire | Senior VP and General Counsel | Sale to Issuer | -49 | $622.18 |
| 2026-08-27 | Lisa Britt | Chief Human Resources Officer & Senior VP | Sale to Issuer | -393 | $622.18 |
| 2026-08-27 | Gianluca Pettiti | Executive Vice President | Sale to Issuer | -1,034 | $622.18 |
| 2026-08-27 | Michael Shafer | Senior VP & President of Pharma Services Group | Sale to Issuer | -790 | $622.18 |
| 2026-08-27 | Joseph Holmes | Vice President | Sale to Issuer | -49 | $622.18 |
| 2026-08-27 | James Meyer | Senior Vice President | Sale to Issuer | -270 | $622.18 |
| 2026-08-23 | Marc Casper | Chairperson & CEO | Derivative Exercise and Sale | -275 | $309.63–628.74 |
| 2026-08-21 | James Meyer | Senior Vice President | Sale to Issuer | -30 | $629.27 |
| 2026-08-20 | Marc Casper | Chairperson & CEO | Derivative Exercise and Sale | -20,000 | $309.63–633.99 |
| 2026-08-20 | Marc Casper | Chairperson & CEO | Intent to Sell (Form 144) | -10,000 | $626.91 |
| 2026-08-19 | Marc Casper | Chairperson & CEO | Intent to Sell (Form 144) | -10,000 | $629.27 |
| 2026-08-18 | Lisa Britt | Chief Human Resources Officer & Senior VP | Derivative Exercise and Sale | -11,440 | $418.32–613.12 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:12 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
赛默飞世尔科技 讨论区 0 条评论